Pharmaceutical Industry Reports Rivaroxaban market | Page 4

REPORT DESCRIPTION
Rivaroxaban Market – Key Players
Major players operating in the global rivaroxaban market include Janssen Pharmaceuticals Inc. and Bayer
AG.
Market players strategize to strengthen their foot hold in the market in spite of high cost by implementing
cost-effective treatment schemes. For instance, Janssen Pharmaceuticals offer Xarelto manufacturer coupon
or patient assistance program to lower the cost of the drug.
Dreadful injuries caused due to Xarelto, has led the company face many legal issues in the U.S. market. For
instance, as of January 30, 2018, Bayer Group had been served in the U.S. with around 22,000 claims of
Xarelto for personal injuries from the use of Xarelto, which includes cerebral, gastrointestinal or other
bleeding and death causes. On clearance of the claims, the market of the product is expected to be affected
in terms of revenue.
Get More Inf @ https://www.coherentmarketinsights.com/market-insight/rivaroxaban-market-1962